Atea Pharmaceuticals, Inc. (AVIR) CEO Jean-Pierre Sommadossi on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/11/21
Atea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on November 11, 2021GlobeNewsWire • 11/04/21
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And MoreBenzinga • 10/25/21
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?The Motley Fool • 10/24/21
AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging TodayInvestorPlace • 10/19/21
Atea Pharmaceuticals stock rocked after disappointing trial results of SARS-CoV-2 pillMarket Watch • 10/19/21
Atea Pharmaceuticals Provides Update and Topline Results for Phase 2 MOONSONG Trial Evaluating AT-527 in the Outpatient SettingGlobeNewsWire • 10/19/21